{"address1": "Friedrich-Miescher-Strasse 15", "city": "T\u00fcbingen", "zip": "72076", "country": "Germany", "phone": "49 7071 9883 0", "website": "https://www.curevac.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "CureVac N.V., a biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202 which is in Phase 1 clinical trial for the treatment of rabies; and CVSQIV to treat multivalent seasonal influenza; Flu SV mRNA fot treating nucleotides, single antigen seasonal influenza. The company develops CV8102, which is in Phase 1 clinical trial for treating melanoma and adenoidcystic carcinoma, as well as squamous cell cancer of skin, head, and neck; and CVGBM for treating cancer. CureVac N.V. was founded in 2000 and is headquartered in T\u00fcbingen, Germany.", "fullTimeEmployees": 999, "companyOfficers": [{"maxAge": 1, "name": "Dr. Alexander  Zehnder M.B.A., M.D.", "age": 54, "title": "CEO, MD & Member of Management Board", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 1058358, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Malte  Greune Ph.D.", "age": 59, "title": "COO, Member of Management Board & MD", "yearBorn": 1965, "fiscalYear": 2023, "totalPay": 649876, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Myriam  Mendila M.D.", "age": 58, "title": "Chief Scientific Officer, Head of R&D, MD & Member of the Management Board", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 664751, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Ulrike  Gnad-Vogt M.D., Ph.D.", "age": 51, "title": "Senior VP & Area Head of Oncology", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 307388, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Axel-Sven  Malkomes", "age": 57, "title": "CFO & Member of Executive Board", "yearBorn": 1967, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thaminda  Ramanayake", "title": "Chief Business Officer & Member of Executive Board", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sarah  Fakih", "title": "Vice President Corporate Communications & Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Marco  Rau L.L.M., Ph.D.", "title": "General Counsel", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Slavica  Stevanovic-Heck", "title": "Head of Human Resources", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Patrick  Baumhof", "title": "Senior Vice President of Technology", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.77, "open": 2.78, "dayLow": 2.71, "dayHigh": 2.81, "regularMarketPreviousClose": 2.77, "regularMarketOpen": 2.78, "regularMarketDayLow": 2.71, "regularMarketDayHigh": 2.81, "payoutRatio": 0.0, "beta": 2.529, "trailingPE": 5.3333335, "forwardPE": -6.1818185, "volume": 836942, "regularMarketVolume": 836942, "averageVolume": 825340, "averageVolume10days": 739010, "averageDailyVolume10Day": 739010, "bid": 2.7, "ask": 2.76, "bidSize": 5, "askSize": 5, "marketCap": 610199360, "fiftyTwoWeekLow": 2.215, "fiftyTwoWeekHigh": 5.28, "priceToSalesTrailing12Months": 9.265239, "fiftyDayAverage": 3.3321, "twoHundredDayAverage": 3.224375, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 446654112, "profitMargins": 0.0, "floatShares": 123543186, "sharesOutstanding": 224338000, "sharesShort": 4058431, "sharesShortPriorMonth": 3741493, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.018099999, "heldPercentInsiders": 0.45263, "heldPercentInstitutions": 0.18000999, "shortRatio": 6.42, "shortPercentOfFloat": 0.1012, "impliedSharesOutstanding": 239616000, "bookValue": 1.679, "priceToBook": 1.6200119, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -278430016, "trailingEps": 0.51, "forwardEps": -0.44, "enterpriseToRevenue": 6.782, "enterpriseToEbitda": -1.652, "52WeekChange": -0.06529212, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 2.72, "targetHighPrice": 16.555002, "targetLowPrice": 2.4821696, "targetMeanPrice": 7.4668574, "targetMedianPrice": 5.0778036, "recommendationMean": 2.33333, "recommendationKey": "buy", "numberOfAnalystOpinions": 6, "totalCash": 202515008, "totalCashPerShare": 0.903, "ebitda": -270342016, "totalDebt": 39035000, "quickRatio": 2.194, "currentRatio": 2.287, "totalRevenue": 65859000, "debtToEquity": 10.367, "revenuePerShare": 0.294, "returnOnAssets": -0.24517, "returnOnEquity": -0.54297, "grossProfits": -86275000, "freeCashflow": -222099008, "operatingCashflow": -289852000, "revenueGrowth": 0.905, "grossMargins": -1.31, "ebitdaMargins": 0.0, "operatingMargins": -4.93579, "financialCurrency": "EUR", "symbol": "CVAC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "exchange": "NGM", "messageBoardId": "finmb_20786046", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "corporateActions": [], "preMarketTime": 1743594448, "regularMarketTime": 1743537601, "regularMarketChangePercent": -1.8050525, "regularMarketPrice": 2.72, "shortName": "CureVac N.V.", "longName": "CureVac N.V.", "marketState": "PRE", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1597411800000, "preMarketChange": 0.0, "preMarketChangePercent": 0.0, "preMarketPrice": 2.72, "regularMarketChange": -0.049999952, "regularMarketDayRange": "2.71 - 2.81", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 825340, "fiftyTwoWeekLowChange": 0.5050001, "fiftyTwoWeekLowChangePercent": 0.22799103, "fiftyTwoWeekRange": "2.215 - 5.28", "fiftyTwoWeekHighChange": -2.5600002, "fiftyTwoWeekHighChangePercent": -0.4848485, "fiftyTwoWeekChangePercent": -6.529212, "earningsTimestampStart": 1745325000, "earningsTimestampEnd": 1745843400, "earningsCallTimestampStart": 1731420000, "earningsCallTimestampEnd": 1731420000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 0.51, "epsForward": -0.44, "epsCurrentYear": 0.83765, "priceEpsCurrentYear": 3.2471797, "fiftyDayAverageChange": -0.6120999, "fiftyDayAverageChangePercent": -0.18369794, "twoHundredDayAverageChange": -0.504375, "twoHundredDayAverageChangePercent": -0.15642565, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-08-14", "averageAnalystRating": "2.3 - Buy", "cryptoTradeable": false, "displayName": "CureVac", "trailingPegRatio": null}